Neuropsychiatric systemic lupus erythematosus

Systemic Lupus Erythematosus, Fourth Edition

Volumn , Issue , 2004, Pages 757-783

  Garcia Cavazos, Rogelio ^a   Brey, Robin ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79953269327     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012433901-9/50029-6     Document Type: Chapter

References (276)

1. American College of Rheumatology (ACR) adhoccommittee on neuropsychiatric lupus (1999) The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndrome. Arthritis Rheum. 42 599-608.
2. C. Drenkard, A.R. Villa, E. Reyes, et al. (1997) Vasculitis in systemic lupus erythematosus. Lupus 6 235-242.
3. M.D. Liem, D.J. Gzesh and A.E. Flanders (1996) MRI and angiographic diagnosis of lupus cerebral vasculitis. Neuroradiology 38 134-136.
4. P.M. Moore (1998) Immune-mediated vasculopathies of the central nervous system. J.M. Gilchrist (Eds) Prognosis in Neurology Melbourne: Butterworth-Heinemann 117-122.
5. J.A. De Marcaida and L. Reik (1999) Central nervous system infections: Disorders that mimic central nervous system infections. Neurol. Clin. 17 901-915.
6. W.L. Sibbitt, R.R. Sibbitt and W.M. Brooks (1999) Neuroimaging in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 42 2026-2038.
7. C. Rivest, R. Lew, P. Welsing, et al. (2000) Association between clinical factors, socioeconomic status, and organ damage in recent onset systemic lupus erythematosus. J. Rheumatol. 27 680-684.
8. N. Futrell, L.R. Schultz and C. Millikan (1992) Central nervous system disease in patients with systemic lupus erythematosus. Neurology 42 1649-1657.
9. A.T. Kaell, M. Shetty, B.C.P. Lee and M.D. Lockshin (1986) The diversity of neurologic events in systemic lupus erythematosus. Arch Neurol 43 273-276.
10. J. McNicholl, D. Glynn, A. Mongey, M. Hutchinson and B. Bresnihan (1994) A prospective study of neurophysiologic, neurologic and immunologic abnormalities in systemic lupus erythematosus. J. Rheumatol. 21 1061-1066.
11. S.G. West, W. Emlen, M.H. Wener and B.L. Kotzin (1995) Neuropsychiatric lupus erythematosus: A 10-year prospective study on the value of diagnostic tests. Am. J. Med. 99 153-163.
12. H. Ainiala, J. Loukkola, J. Peltola, M. Korpela and A. Hietaharju (2001) Prevalence of neuropsychiatric syndromes, in systemic lupus erythematosus. Neurology 57 496-499.
13. R.L. Bry, S.L. Holliday, A.R. Saklad, M.G. Navarrete, D. Hermosillo-Romo, G.L. Stallworth, et al. (2002) Neuropsychiatric syndromes in SLE: Prevalence using standardized definitions in the San Antonio Study of Neuropsychiatric Disease Cohort. Neurology 58 1214-1220.
14. L. Costallat, M. Bertolo and S. Appenzeller (2001) The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes: Analysis of 527 patients. Lupus 10 S32.
15. J.G. Hanly (2001) Neuropsychiatric lupus. Curr. Rheumatol. Rep. 3 205-212.
16. J.G. Hanly, N.M.G. Walsh and V. Sangalang (1992) Brain pathology in systemic lupus erythematosus. J. Rheumatol. 19 732-741.
17. H.M. Belmont, S.B. Abramson and J.T. Lie (1996) Pathology and pathogenesis of vascular injury in systemic, lupus erythematosus: Interactions of inflammatory cells and activated endothelium. Arthritis Rheum. 39 9-22.
18. K. Isshi and S. Hirohata (1998) Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus. Arthritis Rheum. 41 1819-1827.
19. K. Isshi and S. Hirihata (1996) Association of antiribosomal P protein antibodies with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 39 1483-1490.
20. F. Karassa, J.P. Ioannidis, K. Boki, et al. (2000) Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus. Am. J. Med. 109 628-634.
21. W.L. Sibbitt, R.R. Sibbitt and W.M. Brooks (1999) Neuroimaging in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 42 2026-2038.
22. M.R. Gonzalez-Crespo, F.J. Blanco, A. Ramos, et al. (1995) Magnetic resonance of the brain in systemic lupus erythematosus. Br. J. Rheumatol. 34 1055-1060.
23. V.R. Kelley and R.P. Wuthrich (1999) Cytokines in the pathogenesis of systemic lupus erythematosus. Semin. Nephrol. 19 57-66.
24. K.A. Kirou and N.K. Crow (1999) New pieces to the SLE cytokine puzzle. Clin. Immunol. 91 1-5.
25. L.J. Jara, L. Irigoyen, M.J. Ortiz, B. Zazueta, G. Bravo and L.R. Espinoza (1998) Prolactin and interleukin 6 in neuropsychiatric lupus erythematosus. Clin. Rheumatol. 17 110-114.
26. J. Alcocer-Varela, D. Aleman-Hoey and D. Alarcon-Segovia (1992) Interleukin-1 and interleukin 6 activities are increased in the cerebrospinal fluid of patients with CNS lupus erythematosus and correlate with local late T-cell activation markers. Lupus 1 111-117.
27. K. Isshi, S. Hirohata, T. Hashimoto and H. Miyashita (1994) Systemic lupus erythematosus presenting with diffuse low density lesions in the cerebral white matter on computed axial tomography scans: Its implication in the pathogenesis of diffuse central nervous system lupus. J. Rheumatol. 21 1758-1762.
28. E. Kozora, M. Laudenslager, A. Lemieux and S.G. West (2001) Inflammatory and hormonal measures predict neuropsychological functioning in systemic lupus erythematosus and rheumatoid arthritis patients. J. Int. Neuropsychol. Soc. 7 745-754.
29. C. Viedt, G.M. Hansch, R.P. Brandes, W. Kubler and J. Kreuzer (2000) The terminal complement complex C5b-9 stimulates interleukin-6 production in human smooth muscle cells through activation of transcription factors NF-κB and AP-1. FASEB J. 14 2370-2372.
30. M. Shikano, H. Sobajima, H. Yoshikawa, T. Toba, H. Kushimot, H. Katsumata, et al. (2000) Usefulness of a highly sensitive urinary and serum IL-6 assay in patients with diabetic nephropathy. Nephron 85 81-85.
31. S. Kako, T. Nagase and N. Nagata (1999) Circulating levels of interleukin-6, its soluble receptor and interleukin-6/interleukin-6 receptor complexes in patients with type 2 diabetes mellitus. Acta Diabetol. 36 67-72.
32. B.E. van Aken, J. Jansen, S.J. van Deventer and P.H. Reitsma (2000) Elevated levels of homocysteine increase IL-6 production in monocytic Mono Mac 6 cells. Blood Coagul. Fibrinolysis 11 159-164.
33. J.S. Yudkin, M. Kumari, S.E. Humphries and V. Mohamed-Ali (2000) Inflammation, obesity, stress and coronary heart disease: Is interleukin-6 the link? Atherosclerosis 148 209-214.
34. D.G. Young, G. Skibinski, J.I. Mason and K. James (1999) The influence of age and gender on serum dehydroepiandrosterone sulphate (DHEA-S), IL-6, IL-6 soluble receptor (IL-6 sR) and transforming growth factor beta 1 (TGF-betal) levels in normal healthy blood donors. Clin. Exp. Immunol. 117 476-481.
35. R.H. Straub, L. Konecna, S. Hrach, G. Rothe, M. Kreutz, J. Scholmerich, et al. (1998) Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: Possible link between endocrinosenescence and immunose nescence. J. Clin. Endocrinol. Metab. 83 2012-2017.
36. S.F. Maier, L.E. Goehler, M. Fleshner and L.R. Watkins (1998) The role of the vagus nerve in cytokine to-brain communication. Ann. N. Y. Acad. Sci. 840 289-300.
37. W.F. Hickey (1991) T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 28 254-260.
38. C.S. Raine, B. Cannella, A.M. Duijvestijn and A.H. Cross (1990) Homing to the central nervous system vasculature by antigen-specific lymphocytes. II lymphocyte/endothelial cell adhesion during the initial stages of autoimmune demyelination. Lab. Invest. 63 476-489.
39. K. Rossler, C. Neuchrist, O. Kitz, D. Kraft and H. Lassmann (1992) Expression of leukocyte adhesion molecules at the human blood-bran-barrier. J. Neurosci. Res. 31 365-374.
40. C.O.S. Savage and S.P. Cooke (1993) The role of the endotheliumin system vasculitis. J Autoimmunity 6 237-249.
41. Z. Zabry, M.M. Waldschmidt, D. Hendrickson, J. Keiner, L. Love-Homan, F. Takei, et al. (1992) Adhesion molecules on muring brain microvascular endothelial cells: Expression and regulation of ICAM-I and Lgp 55. J. Neuroimmunol. 36 1-11.
42. J.M. Dopp, S.M. Breneman and J.A. Oschowka (1994) Expression of ICAM-1, VCAM-1, L-selectin, and leukosialin in the mouse central nervous system during the induction and remission stages of experimental allergic encephalomyelitis. J. Neuroimmunol. 54 129-144.
43. D. Wong and K. Dorovino-Zis (1992) Upregulation of intercellular adhesion moleculte-1 (ICAM-1) expression in primary cultures of human brain microvascular endothelial cells by cytokines and lipopolysaccharide. J. Neuroimmunol. 39 11-22.
44. H.M. Belmont, J. Buyoh, R. Giorno and S. Abramson (1994) Upregulation of endothelial cell adhesion molecules characterized disease activity in systemic lupus erythematosus. Arthritis Rheum 37 376-383.
45. M.K. Sharief, M.A. Noori, M. Ciardi, A. Cirelli and E.J. Thompson (1993) Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-alpha and blood-brain barrier damage. J. Neuroimmunol. 43 15-21.
46. B.A. Janssen, R.A. Luqmani, C. Gordon, I.H. Hemingway, P.A. Bacon, A.J. Gearing, et al. (1994) Correlation of blood levels of soluble vascular cell adhesion molecule-1 with disease activity in systemic lupus erythematosus and vasculitis. Br. J. Rheumatol. 33 1112-1116.
47. D.A. Horwitz, J.D. Gray, S.C. Behrendsen, et al. (1998) Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus. Arthritis Rheum. 41 838-844.
48. W. Barcellini, G.P. Rizzardi, M.O. Borghi, et al. (1996) In vitro type-1 and type-2 cytokine production in systemic lupus erythematosus: Lack of relationship with clinical disease activity. Lupus 5 139-145.
49. C.A. Dinarello (1999) IL-18: A Th1- inducing, proinflammatory cytokine and new member of the IL-1 family. J. Allergy, Clin. Immunol. 103 11-24.
50. P.P. Sfikakis, D. Charalambopoulos, G. Vayoipoulos, R.P.S. Oglesby and G.C. Tsokos (1994) Increased levels of intercellular adhesion molecule-1 in the serum of patients with SLE. Clin. Exp. Rheumatol. 12 5-9.
51. J. Matsuda, K. Gohchi, M. Gotoh, M. Tsukamoto and N. Saitoh (1994) Circulation intercullular adhesion molecule-1 and soluble interleukin 2-receptor in patients with systemic lupus erythematosus. Eur. J. Haematol. 52 302-303.
52. S.M. Wellicome, P. Kapahi, J.C. Mason, Y. Lebranchu, H. Yarwood and D.O. Haskard (1993) Detection of a circulting form of vascular cell adhesion molecule-1: Raised levels in rheumatoid arthritis and systemic lupus erythematosus. Clin. Exp. Immunol. 92 412-418.
53. P.E. Spronk, H. Bootsma, M.G. Huitema, et al. (1994) Levels of soluble VCAM-I, ICAM-1 and E-Selectin during disease exacerbations in patients with SLE. Clin. Exp. Immunol. 97 439-444.
54. K.P. Machold, H.P. Kiener, W. Graninger, et al. (1993) Soluble ICAM-1 in patients with rheumatoid arthritis and SLE. Clin Immunol. Immunopathol. 68 74-78.
55. C.K. Wong, C.Y. Ho, E.K. Li and C.W.K. Lam (2000) Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4α) concentrations in patients with systemic lupus erythematosus. Lupus 9 589-593.
56. T.A. Fehniger, M.H. Shah, M.J. Turner, et al. (1999) Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: Implications for the innate immune response. J. Immunol. 162 4511-4520.
57. T. Dao, K. Ohashi, T. Kayano, et al. (1997) Interferon γ-inducing factor, a novel cytokine, enhances Fas ligandmediated cytotoxicity of muring T helper cells. Cell Immunol. 173 230-235.
58. K. Egerer, E. Feist, U. Rohr, A. Pruss, G.-R. Burmester and T. Dörner (2000) Increased serum soluble CD14, ICAM-1 and E-selection correlate with disease activity and prognosis in systemic lupus erythematosus. Lupus 9 614-621.
59. R.A. Roubey (1996) Immunology of the antiphospholipid antibody syndrome. Arthritis Rheum. 39 1444-1454.
60. G. Giaradi, S. Pierangeli, V.M. Holers, R. Espinola, X. Lui, N. Harris and J.E. Salmon (2001) Complement activation is required for antiphospholipid antibody induced thrombosis. Arthritis Rheum 44 S162.
61. R.L. Brey and A. Escalante (1998) Neurological manifestations of antiphospholipid antibody syndrome. Lupus 7(Suppl. 2), S67-S74.
62. J.G. Hanly, C. Hong, S. Smith and J.D. Fisk (1999) A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus. Arthritis Rheum. 42 728-734.
63. S.D. Denburg, R.M. Carbott, J.S. Ginsberg and J.A. Denburg (1997) The relationship of antiphospholipid antibodies to cognitive function in patients with systemic lupus erythematosus. J. Int. Neuropsychol. Soc. 3 377-386.
64. S. Menon, E. Jameson-Shortall, S.P. Newman, M.R. Hall-Craggs, R. Chinn and D.A. Isenberg (1999) A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus. Arthritis Rheum. 42 735-741.
65. N.S. Lai and J.L. Lan (2000) Evaluation of cerebrospinal anticardiolipin antibodies in lupus patients with neuropsychiatric manifestations. Lupus 9 353-357.
66. E. Maeshima, S. Maeshima, Y. Yamada and S. Yukawa (1993) Antiphospholipid antibodies and regional cerebral blood flow in systemic lupus erythematosus. Ryumachi 33 125-130.
67. C.H. Kao, J.L. Lan, S.P. ChangLai, K.K. Liao, R.F. Yen and P.U. Chieng (1999) The role of FDG-PET, HMPAO-SPET and MRI in the detection of brain involvement in patients with systemic lupus erythematosus. Eur. J. Nucl. med. 26 129-134.
68. S.R. Mitchell, P.O. Nguyen and P. Katz (1990) Increased risk of neisserial infections in systemic lupus erythematosus. Semin. Arthritis Rheum. 20 174-184.
69. A.G. Iliopoulos and G.C. Tsokos (1996) Immunopathogenesis and spectrum of infections in systemic lupus erythematosus. Semin. Arthritis Rheum. 25 318-336.
70. A.J. Wysenbeek, L. Leibovici and J. Zoldan (1990) Acute central nervous system complications after pulse steroid therapy in patients with systemic lupus erythematosus. J. Rheumatol. 17 1695-1696.
71. O.M. Wolkowitz (1994) Prospective controlled studies of the behavioral and biological effects of exogenous corticosteroids. Psychoneuroendocrinology 19 233-255.
72. O.M. Wolkowitz, H. Weingartner, D.R. Rubinow, et al. (1993) Steroid modulation of human memory: Biochemical correlates. Biol. Psychiatry 33 744-746.
73. J.W. Newcomer, S. Craft, T. Hershey, K. Askins and M.E. Bardgett (1994) Glucocorticoid-induced impairment in declarative memory performance in adult humans. J. Neurosci. 14 2047-2053.
74. A.K. Shak (1996) Reversible MRI lesions (letter). Neurology 46 1188-1189.
75. K. Yaffe, D. Ferriero, A.J. Barkovich and H. Rowley (1995) Reversible MRI abnormalities following seizures. Neurology 45 104-108.
76. A.N. Theofilopoulos (1992) Munne models of lupus. R.G. Lahita (Eds) Systemic Lupus Erythematosus New York: Churchill Livingstone 121-194.
77. D.M. Klinman and A.D. Steinberg (1995) Inquiry into murine and human lupus. Immunol. Rev. 144 157-193.
78. Y. Shoenfeld, M. Blank, R. Aharoni, D. Teitelbaum and R. Arnon (1993) Manipulation of autoimmune disease with T-suppressor cells: Lesions from experimental SLE and EAE. (Letter). Immunology 36 109-116.
79. S.S. Pierangeli and E.N. Harris (1996) In vivo models of thrombosis for the antiphospholipid syndrome. Lupus 5 451-455.
80. I. Krause, M. Blank and Y. Shoenfeld (1996) Immunointerventions in experimental model for antiphospholipid syndrome. Ann. Intern. Med. 147 50-53.
81. R. Merino, M. Iwamoto, L. Fossati, P. Muniesa, K. Araki, S. Takahashi, et al. (1993) Prevention of systemic lupus Erythematosus in autoimmune BXSB mice by a transgene encoding I-3 α-chain. J. Exp. Med. 178 1189.
82. R. Wantanabe-Fukunga, C.I. Brannan, N.G. Copeland, N.A. Jenkins and S. Nagata (1992) Lymphoproliferation disorder in mice explained by defects in fast antigen that mediates apoptosis. Nature 356 314-317.
83. E. Mozes, L.D. Kohn, F. Hakim and D.S. Singer (1993) Resistance of MHC class I-deficient mice to experimental systemic lupus Eryethematosus. Science 261 91-93.
84. P. Lampert and M.B. Oldstone (1973) Host immunoglobulin IgG and complement deposits in the choroids plexus during spontaneous immune complex disease. Science 180 408-410.
85. E.L. Alexander, E.D. Murphy, J.B. Roths and G.E. Alexander (1983) Congenic autoimmune murine models of central nervous system disease in connective tissue disorders. Ann. Neurol. 14 242-248.
86. R.A. Rudick and T.A. Eskin (1983) Neuropathological features of a lupus-like disorder in autoimmune mice. Ann. Neurol. 14 325-332.
87. S.A. Hoffman, D.N. Arbogast, P.M. Ford, D.W. Shucard and R.J. Harbeck (1987) Brain-reactive autoantibody levels in the sera of ageing autoimmune mice. Clin. Exp. Immunol. 70 74-83.
88. K. Nandy, H. Lal, M. Bennett and D. Bennett (1983) Correlation between a learning disorder and elevated brain-reactive antibodies in aged C57BL/6 and young NZB mice. Life Sci. 33 1499-1503.
89. P.M. Moore (1990) Immunoglobulin binding to neuronal cell surface epitopes in murine systemic lupus erythematosus. J. Neuroimmunol. 30 101-109.
90. P.M. Moore (1992) Evidence for bound antineuronal antibodies in brain of NZB/W mice. J. Neuroimmunol. 38 147-154.
91. N.A. Khin and S.T. Hoffman (1993) Brain reactive monoclonal auto-antibodies: Production and characterization. J. Neuroimmunol. 44 137-148.
92. D.C. Hess, M. Taormina, J. Thompson, K.D. Sethi, B. Diamond, R. Rao and D.S. Feldman (1993) Cognitive and neurologic deficits in the MRL/Ipr mouse: A clinicopathologic study. J. Rheumatol. 20 610-617.
93. R.L. Brey, S. Cote and J.M. Teale (1993) Neurological dysfunction and autoantibody producing B Cells from brain in a lupus-prone mouse strain. Neurology 43 420.
94. L.M. Schrott, L. Morrison, R. Wimer, C. Wimer, P.O. Behan and V.H. Denenberg (1994) Autoimmunity and avoidance learning in NXRF recombinant inbred strains. Brain Behav. Immunol. 8 100-110.
95. M.J. Forester, K.C. Retz and H. Lal (1988) Learning and memory deficits associated with autoimmunity: Significance in aging and Alzheimers' disease. Drug Dev. Res. 15 253-273.
96. B. Sakic, H. Szechtman, S.D. Denburg, R.M. Carbotte and J.A. Denburg (1993) Brain-reactive antibodies and behavior of autoimmune MRL-Ipr mice. Physiol. Behav. 54 1025-1029.
97. A.B. Keir (1990) Clinical neurology and brain histopathology I NZB/NZW F1 lupus mice. J. Comp. Pathol. 102 165-177.
98. C.M. Vogelweid, G.C. Hohnson, C.L. Besch-Williford, J. Basler and S.E. Walker (1991) Inflammatory central nervous system disease in lupus-prone MRL/lpr mice: Comparative histologic and immunohistochemical findings. J. Neuroimmunol. 35 89-99.
99. R.L. Brey, S. Cote and J.M. Teale (1993) Neurological dysfunction and autoantibody producing B cells from brain in alupus-prone mouse strain. Neurology 43 420.
100. B. Sakie, H. Szechtman, M. Keffer, H. Talangbayan, R. Stead and J.A. Denburg (1992) A behavioral profile of autoimmune lupus-prone MRL mice. Brain Behav. Immunol. 6 265-285.
101. B. Sakie, H. Szechtman, H. Talangbayan, S.D. Denburg, R.M. Carbotte and J.A. Denburg (1994) Behaviour and immune status of MRL mice in the postweaning period. Brain Behav. Immunol. 8 1-13.
102. B. Sakie, H. Szechtman, R. Stead and J.A. Denburg (1996) Joint pathology and behavioral performance in autoimmune MRL-lpr mice. Physiol. Behav. 60 901-905.
103. B. Sakie, H. Szechtman, H. Talangbayan, S.D. Denburg, R.M. Carbotte and J.A. Denburg (1994) Disturbed emotionality in autoimmune MRL-lpr mice. Physiol. Behav. 56 609-617.
104. B. Sakie, J.A. Denburg, S.D. Denburg and H. Szechtman (1996) Blunted sensitivity to sucrose reward in autoimmune MRL-lpr mice: A curve-shift study. Brain Res. Bull. 41 305-311.
105. L.S. Crnic and L.M. Schrott (1996) Increased anxiety behaviors in autoimmune mice. Behav. Neurosci. 110 492-502.
106. L. Ziporen, D. Eilam, L. Goldberg, A. Afek, S. Polak, A. Bardea, A. Mike, Y. Kopoloivc, A.D. Korzcyn and Y. Shoenfeld (1996) Neurological dysfunctions associated with antiphospholipid antibodies: Animal model. Lupus 5 533.
107. A.L. Aron, M.L. Cuellar, R.L. Brey, A.E. Gharavi and Y. Shoenfeld (1995) Early onset of autoimmunity in MRL/++ mice following immunization with beta-2-glycoprotein 1. Clin. Exp. Rheum. Immunol. 101 78-81.
108. R.L. Brey, S.A. Cote, L. Zhongren and J. Teale (1995) Central nervous system dysfunction is accelerated in autoimmune-prone mice immunized with neuronal surface proteins. Neurology 45 205.
109. http://www.rheumatology.org/ar/1999/aprilappendix.html
110. P. Lesprit, F. Mouloud, P. Bierling, A. Schaffer, P. Cesaro, C. Brun-Buisson and B. Godeau (1996) Prolonged remission of SLE-associated polyradiculoneuropathy after a single course of intravenous immunoglobulin. Scand. J. Rheumatol. 25 177-179.
111. E. Rechthand, D.R. Cornblath, B.J. Stern and J.O. Meyerhoff (1984) Chronic demyelinating polyneuropathy in systemic lupus erythematosus. Neurology 34 1375-1377.
112. T.J. Millette, S.H. Subramony, A.S. Wee and V. Harisdangkul (1986) Systemic lupus erythematosus presenting with recurrent acute demyelinating polyneuropathy. Eur. Neurol. 25 397-402.
113. J.A.J. Kovacs, M.B. Urowitz and D.D. Gladman (1993) Dilemmas in neuropsychiatric lupus. Rheum. Dis. Clin. North. Am. 19 795-813.
114. S.G. West (1994) Neuropsychiatric lupus. Rheum. Dis. Clin. North Am. 20 129-158.
115. C.C. Mok, C.S. Lau and R.W.S. Wong (2001) Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus. J. Rheumatol. 28 766-771.
116. J.J. Canoso and A.S. Cohen (1975) Aspectic meningitis in systemic lupus erythematosus. Report of three cases. Arthritis Rheum. 18 369-374.
117. M.L. Sands, M. Ryczak and R.B. Brown (1988) Recurrent aseptic meningitis followed by transverse myelitis as a presentation of systemic lupus erythematosus. J. Rheumatol. 15 862-864.
118. M.E. Lancman, H. Mesropian and R.J. Granillo (1989) Chronic aseptic meningitis in a patient with systemic lupus erythematosus. Can. J. Neurol. Sci. 16 354-356.
119. C. Hoyle, D.J. Ewing and A.C. Parker (1985) Acute autonomic neuropathy in association with systemic lupus erythematosus. Ann. Rheum. Dis. 44 420-424.
120. J.I. Gamez-Nava, L. González-Lopez, C. Ramos-Remus, M.M. Fonseca-Gomez, E.G. Cardona-Muñoz and M.E. Suárez-Almazor (1998) Autonomic dysfunction in patients with systemic lupus erythematosus. J. Rheumatol. 25 1092-1096.
121. F. Liote and C.K. Osterland (1994) Autonomic neuropathy in systemic lupus erythematosus: Cardiovascular autonomic function assessment. Ann. Rheum. Dis. 53 671-674.
122. L. Altomonte, L. Mirone, A. Zoli and M. Magaro (1997) Autonomic nerve dysfunction in systemic lupus erythematosus: Evidence for a mild involvement. Lupus 6 441-444.
123. R.H. Straub, M. Zauner, G. Lock, H. Rath, R. Hein, J. Scholmerich and B. Lang (1996) Autonomic and sensorimotor neuropathy in patients with systemic lupus erythematosus and systemic sclerosis. J. Rheumatol. 23 87-92.
124. C.J. Mathias (1997) Autonomic disorders and their recognition. N. Engl. J. Med. 336 721-724.
125. L.F. Haas (1982) Stroke as an early manifestation of systemic lupus erythematosus. J. Neurol. Neurosurg. Psychiatry 45 554-556.
126. M. Vidailhet, J.C. Piette, B. Wechsler, M.G. Bousser and P. Brunet (1990) Cerebral venous thrombosis in systemic lupus erythematosus. Stroke 21 1226-1231.
127. E.N. Harris, A.E. Gharavi, R.A. Asherson, M.L. Boey and G.R. Hughes (1984) Cerebral infarction in systemic lupus: Association with anticardiolipin antibodies. Clin. Exp. Rheumatol. 2 47-51.
128. R.L. Brey, A.E. Gharavi and M.D. Lockshin (1990) Neurologic complications of antiphospholipid antibodies. Rheum. Dis. Clin. North Am. 19 833-850.
129. G.C. Tsokos, M. Tsokos, N.G.H. leRiche and J.H. Klippel (1986) A clinical and pathologic study of cerebrovascular disease in patients with systemic lupus erythematosus. Semin. Arthritis Rheum. 16 70-78.
130. A. Sivri, Z. Hasçelik, R. Çeliker and O. Başgöze (1995) Early detection of neurological involvement in systemic lupus erythematosus. Electromyogr. Clin. Neurophysiol. 35 195-199.
131. R. Omdal, O.A. Henriksen, S.I. Mellgren and G. Husby (1991) Peripheral neuropathy in systemic lupus erythematosus. Neurology 41 808-811.
132. C. Huynh, S.L. Ho, K.Y. Fong, R.T.F. Cheung, C.C. Mok and C.S. Lau (1999) Peripheral neuropathy in systemic lupus erythematosus. J. Clin. Neurophysiol. 16 164-168.
133. R.A.C. Hughes, J.S. Cameron, S.M. Hall, J. Heaton, J. Payan and R. Teoh (1982) Multiple mononeuropathy as the initial presentation of systemic lupus erythematosus—nerve biopsy and response to plasma exchange. J. Neurol. 228 239-247.
134. S.L. Bloch, M.P. Jarrett, M. Swerdlow and A.I. Grayzel (1979) Brachial plexus neuropathy as the initial presentation of systemic lupus erythematosus. Neurology 29 1633-1634.
135. R. Omdal, S. Løseth, T. Torbergsen, W. Koldingsnes, G. Husby and S.I. Mellgren (2001) Peripheral neuropathy in systemic lupus erythematosus—a longitudinal study. Acta Neurol. Scand. 103 386-391.
136. L. Harel, M. Mukamel, R. Brik, H. Blau and R. Straussberg (2002) Peripheral neuropathy in pediatric systemic lupus erythematosus. Pediatr. Neurol. 27 53-56.
137. Y. Matsuki, T. Hidaka, M. Matsumoto, et al. (1999) Systemic lupus erythematosus demonstrating serum anti-GM1 antibody with sudden onset of drop foot as the initial presentation. Intern. Med. 38 729-732.
138. B. Fierro, F. Brighina, L. Amico, et al. (1999) Evoked potential study and radiological findings in patients with systemic lupus erythematosus. Electromyogr. Clin. Neurophysiol. 39 305-513.
139. M.G. Sabbadini, A.A. Manfredi, E. Bozzolo, et al. (1999) Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations. Lupus 8 11-19.
140. R. Omdal, S.I. Mellgren, L. Gøransson, A. Skjesol, S. Lindal, W. Koldingsnes and G. Husby (2002) Small nerve fiber involvement in systemic lupus erythematosus. A controlled study. Arthritis Rheum. 46 1228-1232.
141. R. Omdal, S.I. Mellgren, G. Husby, R. Salvesen, O.A. Henriksen and T. Torbergsen (1993) A controlled study of peripheral neuropathy in systemic lupus erythematosus. Acta Neurol. Scand. 88 41-46.
142. P.A. McCombe, J.G. McLeod, J.D. Pollard, Y.-P. Guo and T.J. Ingall (1987) Peripheral sensorimotor and autonomic neuropathy associated with systemic lupus erythematosus. Brain 110 533-549.
143. L. Scheinberg (1956) Polyneuritis in systemic lupus erythematosus. Review of the literature and report of a case. N. Engl. J. Med. 255 416-421.
144. I. Bódi, P. Váradi, G. Pokorny, J. Engelhardt, G. Dibó, L. Vécseri and T.L. Miko (1998) Polyneuropathy with endoneurial immune complex deposition as the first manifestation of systemic lupus erythematosus. Acta Neuropathol. 96 297-300.
145. S. Genevay, G. Hayem, S. Hamza, E. Palazzo, O. Meyer and M.F. Kahn (2002) Oculomotor palsy in six patients with systemic lupus erythematosus. A possible role of antiphospholipid syndrome. Lupus 11 313-316.
146. J.S. Lee, Y.B. Roh, B.S. Oum and I.S. Kwak (2000) Isolated oculomotor nerve palsy with pupillary abnormality in systemic lupus erythematosus. J. Pediatr. Ophthalmol. Strabismus 37 241-243.
147. L.A. Sedwick and R.M. Burde (1983) Isolated sixth nerve palsy as initial manifestation of systemic lupus erythematosus. A case report. J. Clin. Neuro-Ophthalmol. 3 109-110.
148. E.D. Rosenstein, J. Sobelman and N. Kramer (1989) Isolated, pupil-sparing third nerve palsy as initial manifestation of systemic lupus erythematosus. J. Clin. Neuro-Ophthalmol. 9 285-288.
149. A.S. Friedman, V. Folkert and G.A. Khan (1995) Recurrence of systemic lupus erythematosus in a hemodialysis patient presenting as a unilateral abducens nerve palsy. Clin. Nephrol. 44 338-339.
150. J.R. Keane (1995) Eye movement abnormalities in systemic lupus erythematosus. Arch. Neurol. 52 1145-1149.
151. D.A. Blaustein and S.A. Blaustein (1998) Antinuclear antibody negative systemic lupus erythematosus presenting as bilateral facial paralysis. J. Rheumatol. 25 798-800.
152. P.O. Lundberg and I. Werner (1972) Trigeminal sensory neuropathy in systemic lupus erythematosus. Acta Neurol. Scand. 48 330-340.
153. T. Vyse, L.M. Luxon and M.J. Walport (1994) Audiovestibular manifestations of the antiphospholipid syndrome. J. Laryngol. Otol. 108 57-59.
154. A.P. Andonopoulos, S. Naxakis, P. Goumas and C. Lygatsikas (1995) Sensorineural hearing disorders in systemic lupus erythematosus. A controlled study. Clin. Exp. Rheumatol. 13 137-141.
155. J.H. Vaile and P. Davis (1998) Isolated unilateral vagus nerve palsy in systemic lupus erythematosus. (Letter). J. Rheumatol. 25 2287-2288.
156. S. Saluja, R.R. Singh, A. Misra, A.K. Gairola, K. Prasad, G.K. Ahuja and A.N. Malaviya (1989) Bilateral recurrent laryngeal nerve palsy in systemic lupus erythematosus. Clin. Exp. Rheumatol. 7 81-83.
157. T. Gordon and E.C. Dunn (1990) Systemic lupus erythematosus and right recurrent laryngeal nerve palsy. Br. J. Rheumatol. 29 308-309.
158. C.N. Chan, E. Li, F.M. Lai and J.A. Pang (1989) An unusual case of systemic lupus erythematosus with isolated hypoglossal nerve palsy, fulminant acute pneumonitis, and pulmonary amyloidosis. Ann. Rheum. Dis. 48 236-239.
159. J.B. Sloan, M.A. Berk, H.M. Gebel and D.F. Fretzin (1987) Multiple sclerosis and systemic lupus erythematosus: Occurrence in two generations of the same family. Arch. Intern. Med. 147 1317-1320.
160. P.E. Kaplan and H.B. Betts (1977) Lupoid sclerosis: Evaluation and treatment. Arch. Phys. Med. Rehabil. 58 24-28.
161. E. Kinnunen, K. Muller, P. Keto, L. Ketonen, T. Helve and R. Sepponen (1993) Cerbrospinal fluid and MRI findings in three patients with multiple sclerosis and systemic lupus erythematosus. Acta Neurol. Scand. 78 356-360.
162. P.A. McCombe, J.B. Chalk and M.P. Pender (1990) Familial occurrence of multiple sclerosis, thyroid disease and systemic lupus erythematosus. J. Neurol. Sci. 97 163-171.
163. T.F. Scott, D. Hess and J. Brillman (1994) Antiphospholipid antibody syndrome mimicking multiple sclerosis and systemic lupus erythematosus clinically and by magnetic resonance imaging. Arch. Intern. Med. 154 917-920.
164. L.A. Rolak (1996) The diagnosis of multilple sclerosis. Neurol. Clin. 14 27-43.
165. D. Giorgi and C. Balacco Gabrieli (1999) Optic neuropathy in systemic lupus erythematosus and antiphospholipid syndrome (APS): Clinical features, pathogenesis, review of the literature and proposed ophthalmological criteria for APS diagnosis. Clin. Rheumatol. 18 124-131.
166. S.R. Levine, J.W. Crofts, G.R. Lesser, J. Floberg and K.M. Welch (1988) Visual symptoms associated with the presence of a lupus anticoagulant. Ophthalmology 95 686-692.
167. S. Oppenheimer and B.I. Hoffbrand (1986) Optic neuritis and myelopathy in systemic lupus erythematosus. Can. J. Neurol. Sci. 13 129-132.
168. G. Galindo-Rodriguez, J.A. Avina-Zubieta, S. Pizarro, V. Diaz de Leon, N. Saucedo, M. Fuentes and C. Lavalle (1999) Cyclophosphamide pulse therapy in optic neuritis due to systemic lupus erythematosus: An open trial. Am. J. Med. 106 65-69.
169. R.S. April and E. Vansonnenberg (1976) A case of neuromyelitis optica (Devic's syndrome) in systemic lupus erythematosus. Clinopathologic report and review of the literature. Neurology 26 1066-1070.
170. J.T. Rosenbaum J>T., J. Simpson and C.M. Neuwelt (1997) Successful treatment of optic neuropathy in association with systemic lupus erythematosus using intravenous cyclophosphamide. Br. J. Ophthalmol. 81 130-132.
171. D. Giorgi, C. Balacco Gabrieli and L. Bonomo (1999) The association of optic neuropathy with transverse myelitis in systemic lupus erythematosus. (Letter). Rheumatology 38 191-192.
172. D.A. Jabs, N.R. Miller, S.A. Newman, M.A. Johnson and M.B. Stevens (1986) Optic neuropathy in systemic lupus Erythematosus. Arch. Ophthalmol. 104 564-568.
173. F. Bonnet, P. Mercie, P. Morlat, C. Hocke, C. Vergnes, E. Ellie, J.F. Viallard, I. Faure, J.L. Pellegrin, J. Beylot and B. Leng (1999) Devic's neuromyelitis optica during pregnancy in a patient with systemic lupus erythematosus. Lupus 8 244-247.
174. R.J. Cinefro and M. Frenkel (1978) Systemic lupus erythematosus presenting as optic neuritis. Ann. Ophthalmol. 10 559-563.
175. C.A. Smith and R.S. Pinals (1982) Optic neuritis in systemic lupus erythematosus. J. Rheumatol. 9 963-966.
176. A.A. Andrianakos, J. Duffy, M. Suzuki and J.T. Sharp (1975) Transverse myelopathy in systemic lupus erythematosus. Report of three cases and review of the literature. Ann. Intern. Med. 83 616-624.
177. H.J. Hachen and A. Chantraine (1979) Spinal cord involvement in systemic lupus erythematosus. Paraplegia 17 337-346.
178. C.C. Mok, C.S. Lau, E.Y. Chan and R.W. Wong (1998) Acute transverse myelopathy in systemic lupus erythematosus: Clinical presentation, treatment, and outcome. J. Rheumatol. 25 467-473.
179. B. Kovacs, T.L. Lafferty, L.H. Brent and R.J. DeHoratius (2000) Transverse myelopathy in systemic lupus erythematosus: An analysis of 14 cases and review of the literature. Ann. Rheum. Dis. 59 120-124.
180. V. Schantz, L.L. Oestergaard and P. Junker (1998) Shrinking spinal cord following transverse myelopathy in a patient with systemic lupus erythematosus and the phospholipid antibody syndrome. J. Rheumatol. 25 1425-1428.
181. L. Barile and C. Lavalle (1992) Transverse myelitis in systemic lupus erythematosus—the effect of IV pulse methylprednisolone and cyclophosphamide. J. Rheumatol. 19 370-372.
182. R.W. Warren and D.W. Kredich (1984) Transverse myelitis and acute central nervous system manifestations of systemic lupus erythematosus. Arthritis Rheum. 27 1058-1060.
183. M. Marabani, A. Zoma, D. Hadley and R.D. Sturrock (1989) Transverse myelitis occurring during pregnancy in a patient with systemic lupus erythematosus. Ann. Rheum. Dis. 48 160-162.
184. J. Provenzale and T.W. Bouldin (1992) Lupus-related myelopathy: Report of three cases and review of the literature. J. Neurol. Neurosurg. Psychiatry 55 830-835.
185. D.J. Propper and R.C. Bucknall (1989) Acute transverse myelopathy complicating systemic lupus erythematosus. Ann. Rheum. Dis. 48 512-515.
186. J.M. Provenzale, D.P. Barboriak, E.H.L. Gaensler, R.L. Robertson and B. Mercer (1994) Lupus-related myelitis: Serial MR findings. Am. J. Neuroradiol. 15 1911-1917.
187. P.P. Sfikakis, D.D. Mitsikostas, M.N. Manoussakis, D. Foukaneli and H.M. Moutsopoulos (1998) Headache in systemic lupus erythematosus: A controlled study. Br. J. Rheumatol. 37 300-303.
188. A. Fernández-Nebro, R. Palacios-Muñoz, J. Gordillo, M. Abarca-Costalago, M. De Haro-Liger, J. Rodríguez-Andreu and P. González-Santos (1999) Chronic or recurrent headache in patients with systemic lupus erythematosus: A case control study. Lupus 8 151-156.
189. B.I. Glanz, A. Venkatesan, P.H. Schur, R.A. Lew and S. Khoshbin (2001) Prevalence of migraine in patients with systemic lupus erythematosus. Headache 41 285-289.
190. R.A. Atkinson and O. Appenzeller (1975) Headache in small vessel disease of the brain: A study of patients with systemic lupus erythematosus. Headache 15 198-201.
191. D.A. Isenberg, D. Meyrick-Thomas, M.L. Snaith, R.O. McKeran and J.P. Royston (1982) A study of migraine in systemic lupus erythematosus. Ann. Rheum. Dis. 41 30-32.
192. J. Vázquez-Cruz, H. Traboulssi, A. Rodriguez-De la Serna, C. Geli, C. Roig and C. Díaz (1990) A prospective study of chronic or recurrent headache in systemic lupus erythematosus. Headache 30 232-235.
193. C.L. Rozell, W.L. Sibbitt Jr. and W.M. Brooks (1998) Structural and neurochemical markers of brain injury in the migraine diathesis of systemic lupus erythematosus. Cephalalgia 18 209-215.
194. H.S. Markus and N. Hopkinson (1992) Migraine and headache in systemic lupus erythematosus and their relationship with antibodies against phospholipids. J. Neurol. 239 39-42.
195. K.D. Brandt and S. Lessell (1978) Migrainous phenomena in systemic lupus erythematosus. Arthritis Rheum. 21 7-16.
196. J. Montalban, R. Cervera, J. Font, J. Ordi, J. Vianna, H.J. Haga, M. Tintore, M.A. Khamashta and G.R.V. Hughes (1992) Lack of association between anticardiolipin antibodies and migraine in systemic lupus erythematosus. Neurology 42 681-682.
197. R. Omdal, K. Waterloo, W. Koldingsnes, G. Husby and S.I. Mellgren (2001) Somatic and psychological features of headache in systemic lupus erythematosus. J. Rheumatol. 28 772-779.
198. R. Cervera, R.A. Asherson, J. Font, M. Tikly, L. Pallares, A. Chamorro and M. Ingelmo (1997) Chorea in the antiphospholipid syndrome: Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature. Medicine 76 203-212.
199. M.A. Khamashta, A. Gil, B. Anciones, P. Lavilla, M.E. Valencia, V. Pintado and J.J. Vázquez (1988) Chorea in systemic lupus erythematosus: Association with antiphospholipid antibodies. Ann. Rheum. Dis. 47 681-683.
200. E. Venegoni, R. Biasioli, E. Lamperti, E. Rinaldi, A. Salmaggi and C. Novi (1994) Tremor as an early manifestation of systemic lupus erythematosus. Clin. Exp. Rheumatol. 12 199-201.
201. R.E. Wolf and J.G. McBeath (1985) Chorea gravidarum in systemic lupus erythematosus. J. Rheumatol. 12 992-993.
202. R.A. Asherson, R.H.W.M. Derksen, E.N. Harris, B.N. Bouma, A.E. Gharavi, L. Kater and G.R.V. Hughes (1987) Chorea in systemic lupus erythematosus and “lupus-like” disease: Association with antiphospholipid antibodies. Semin. Arthritis Rheum. 16 253-259.
203. P.Y. Hatron, B. Bouchez, A. Wattel, G. Arnott and B. Devulder (1986) Chorea, systemic lupus, circulating lupus anticoagulant. (Letter). J. Rheumatol. 13 991-993.
204. R.A. Asherson, N.E. Harris, A.E. Gharavi and G.R.V. Hughes (1986) Systemic lupus erythematosus, antiphospholipid antibodies, chorea, and oral contraceptives. (Letter). Arthritis Rheum. 29 1536-1539.
205. R. Cervera, M.A. Khamashta, J. Font, G.D. Sebastiani, A. Gil, P. Lavilla, I. Domenech, A.O. Aydintug, A. Jedryka-Goral, E. de Ramon, et al. (1993) Systemic lupus erythematosus: Clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine 72 113-124.
206. J.O. Lusins and P.A. Szilagyi (1975) Clinical features of chorea associated with systemic lupus erythematosus. Am. J. Med. 58 857-861.
207. J.E. Olsen (1968) Chorea minor associated with systemic lupus erythematosus. Report of a case. Acta. Med. Scand. 183 127-129.
208. G.W. Bryun and G. Padberg (1984) Chorea and systemic lupus erythematosus. A critical review. Eur. Neurol. 23 278-290.
209. S.M. Wolf and H.S. Barrows (1966) Myasthenia gravis and systemic lupus erythematosus. Arch. Neurol. 14 254-258.
210. P. Petersen and J. Lund (1969) Systemic lupus erythematosus following thymectomy for myasthenia gravis. Danish Med. Bull. 16 179-181.
211. G. Abbruzzese, M. Abbruzzese, A. Bacigalupo and S. Ratto (1979) Systemic lupus erythematosus after thymectomy in a patient with myasthenia gravis. (Letter). Neurology 29 1436-1437.
212. M.K.L. Chan and M. Britton (1980) Comparative clinical features in patients with myasthenia gravis with systemic lupus erythematosus. J. Rheumatol. 7 838-842.
213. P.J. Killian and G.S. Hoffman (1980) Coexistence of systemic lupus erythematosus and myasthenia gravis. South. Med. J. 73 244-246.
214. G. Vaiopoulos, P.P. Sfikakis, V. Kapsimali, K. Boki, P. Panayiotidis, A. Aessopos, G.C. Tsokos and P. Kaklamanis (1994) The association of systemic lupus erythematosus and myasthenia gravis. Postgrad. Med. J. 70 741-745.
215. F. Meloni, N. Gueli, S. Villatico Campbell, F. Di Maio, M.G. Di Bernardo, M. Di Nuzzo and G. Carmenini (1996) A case of systemic lupus erythematosus (SLE) and myasthenia gravis (MG). Allergy 51 362-363.
216. R.E. Barbosa, S. Cordova and J.C. Cajigas (2000) Coexistence of systemic lupus erythematosus and myasthenia gravis (Letter). Lupus 9 156-162.
217. D. Mevorach, S. Perrot, N.M. Buchanan, M. Khamashta, S. Laoussadi, G.R. Hughes and C.J. Menkes (1995) Appearance of systemic lupus erythematosus after thymectomy: Four case reports and review of the literature. Lupus 4 33-37.
218. M.L. Scheuer and T.A. Pedley (1990) The evaluation and treatment of seizures. N. Engl. J. Med. 323 1468-1472.
219. M.T. Herranz, G. Rivier, M.A. Khanashta, K.U. Blaser and G.R.V. Hughes (1994) Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. Arthritis Rheum. 37 568-571.
220. A.P. van Dam (1991) Diagnosis and pathogenesis of CNS lupus. Rheumatol. Int. 11 1-11.
221. C.G. Mackworth-Young and G.R.V. Hughes (1985) Epilepsy: An early symptom of systemic lupus erythematosus. J. Neurol. Neurosurg. Psychiatry 48 185-192.
222. R.J. Feinglass, F.C. Arnett, C.A. Dorsch, T.M. Zizic and M.B. Stevens (1997) Neurological manifestations of systemic lupus erythematosus: Diagnosis, clinical spectrum, and relationship to other features of the disease. Medicine 55 323-339.
223. W.J. McCure and J. Globus (1988) Neuropsychiatric lupus. Rheum. dis. Clin. North Am. 14 149-167.
224. A.G. Tzioufas, N.G. Tzortzakis, E. Panou-Pomonis, et al. (2000) The clinical relevance of antibodies to ribosomal-P common epitope in two targeted systemic lupus erythematosus populations: A large cohort of consecutive patients and patients with active central nervous system disease. Ann. Rheum. Dis. 59 99-104.
225. K. Waterloo, R. Omdal, G. Husby, et al. (2001) Neuropsychological function in SLE: A five year longitudinal study. Lupus 10(Suppl. 1), 35.
226. M.G. Sabbadini, A.A. Manfredi, E. Bozzolo, et al. (1999) Central nervous system involvement in SLE patients without overt neuropsychiatric manifestations. Lupus 8 11-19.
227. S. Yalaoui, Y. Gorgi, R. Hajri, R. Goucha, L. Chaabouni, C. Kooli and K. Ayed (2002) Autoantibodies to ribosomal P proteins in systemic lupus erythematosus. Joint, Bone, Spine: Revue du Rhumatisme 69 173-176.
228. F.C. Arnett, J.D. Reveille, H.M. Moutsopoulos, et al. (1996) Ribosomal P antibodies in systemic lupus erythematosus. Arthritis Rheum. 39 1833-1839.
229. F. Formiga, I. Moga, M. Pac, et al. (1999) Mild presentation of systemic lupus erythematosus in elderly patients assessed by SLEDAI. Lupus 8 462-465.
230. L. Carreño, F.J. Lopez-Longo, I. Monteagudo, et al. (1999) Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus. Lupus 8 287-292.
231. J. Font, R. Cervera, G. Espinosa, et al. (1998) Systemic lupus erythematosus in childhood: Analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann. Rheum. Dis. 57 456-459.
232. J. Antolin, M.J. Amerigo, A. Cantabrana, et al. (1995) Systemic lupus erythematosus: Clinical manifestations and immunological parameters in 194 patients. Subgroup classification of SLE. Clin. Rheumatol. 14 678-685.
233. R.S. Duriseti (2001) Lupus. Medicine 2 1-12.
234. M. Segasothy and P. Phillips (2001) Systemic lupus erythematosus in Aborigines and Caucasians in Central Australia: A comparative study. Lupus 10 439-444.
235. M. Petri (1998) The effect of race on the presentation and course of SLE in the United States. Lupus 7 S22.
236. E. Cucurull, A.E. Gharavi, E. Diri, et al. (1999) IgA anticardiolipin and anti-β2-glycoprotein I are the most prevalent isotypes in African American patients with systemic lupus erythematosus. Am. J. Med. Sci. 318 55-60.
237. A. Ghirardello, A. Doria, S. Zampieri, et al. (2000) Antiribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: Their specificity for SLE and association with IgG anticardiolipin antibodies. Ann. Rheum. Dis. 59 975-981.
238. C.H. Kao, Y.J. Ho, J.L. Lan, S.P. Changlai, K.K. Liao and P.U. Chieng (1999) Discrepancy between regional cerebral blood flow and glucose metabolism of the brain in systemic lupus erythematosus patients with normal brain magnetic resonance imaging findings. Arthritis Rheum. 42 61-68.
239. S.M. Weiner, A. Otte, M. Schumacher, R. Klein, J. Gutfleisch, I. Brink, et al. (2000) Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: Value of F-18 fluorodeoxyglucose PET. Ann. Rheum. Dis. 59 377-385.
240. A. Otte, S.M. Weiner, H.H. Peter, J. Mueller-Brand, M. Goetze, E. Moser, et al. (1997) Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: A controlled positron emission tomography study. Eur. J. Nucl. Med. 24 787-791.
241. N. Komatsu, K. Kodama, N. Yamanouchi, S. Okada, S. Noda, Y. Nawata, et al. (1999) Decreased regional metabolic rate for glucose in systemic lupus erythematosus patients with psychiatric symptoms. Eur. Neurol. 42 41-48.
242. R.J.S. Chinn, I.D. Wilkinson, M.A. Hall-Craggs, et al. (1997) Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosus. Arthritis Rheum. 40 36-46.
243. R. Omdal, B. Selseth, N.E. Klow, G. Husby and S.I. Mellgren (1989) Clinical neurological, electrophysiological and cerebral CT scans findings in systemic lupus erythematosus. Scand. J. Rheumatol. 18 283-289.
244. M.M. Ward, E. Pyun and S. Studenski (1996) Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus. Arch. Intern. Med. 156 1337-1344.
245. A.J. Swaak, H.G. van den Brink, R.J. Smeenk, et al. (1999) Systemic lupus erythematosus: Clinical features in patients with a disease duration of over 10 years, first evaluation. Rheumatology 38 953-958.
246. A.J. Swaak, H.G. van den Brink, R.J. Smeenk, et al. (2001) Systemic lupus erythematosus. Disease outcome in patients with disease duration of at least 10 years: Second evaluation. Lupus 10 51-58.
247. T. Abel, D.D. Gladmen and M.B. Urowitz (1980) Neuropsychiatric lupus. J. Rheumatol. 7 325-333.
248. T. Gibson and A.R. Myers (1976) Nervous system involvement in systemic lupus erythematosus. Ann. Rheum. Dis. 35 398-406.
249. R.J. Cook, D.D. Gladman, D. Pericak and M.B. Urowitz (2000) Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity. J. Rheumatol. 27 1892-1895.
250. M.M. Ward, E. Pyun and S. Studenski (1996) Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus. Arch. Intern. Med. 156 1337-1344.
251. Y. Shoenfeld and M. Khamashta (Eds) (2001) Special Issue: Old treatment/new treatment. Lupus 3 1-248.
252. G. Navarrete and R.L. Brey (2000) Neuropsychiatric systemic lupus erythematosus. Curr. Treat. Options Neurol. 2 473-485.
253. V. Strand (2000) New therapies for systemic lupus erythematosus. Rheum. Dis. Clin. North Am. 26 1-16.
254. R.F. van Vollenhoven (2000) Dehydroepiandrosterone in systemic lupus erythematosus. Rheum. Dis. Clin. North Am. 26 135-145.
255. R.F. van Vollenhoven, D. Elliot, M. Powell, et al. (2001) Dehydroepiandrosterone improves cognitive function in patients with systemic lupus erythematosus: Results of a double-blinded, placebo controlled pilot study. Lupus 10(Suppl. 1), S51.
256. L. Barile, L. Olguin, R. Ariza, et al. (2001) Controlled clinical trial of cyclophosphamide, vs. methylprednisolone in severe neurologic manifestations in SLE. Lupus 10 S34.
257. V. Bellomio, A. Spindler and S. Cunio (2001) Cyclophosphamide in systemic lupus erythematosus: Cumulative dose and adverse events. Lupus 10 S104.
258. V.F. Trevisani, A.A. Castro, J.F. Neves-Neto and A.N. Atallah (2000) Cyclophosphamide versus methylprednisolone for the treatment of neuropsychiatric involvement in systemic lupus erythematosus. Cochrane Database Syst. Rev. 3 CD002265
259. A.E. Traynor, J. Schroeder, R. Rosa, et al. (2000) Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and hematopoietic stem-cell transplantation: a phase I study. Lancet 356 701-707.
260. R.D. Hughes (1991) Ineffectiveness of high-dose intravenous methylprednisolone in Guillain-Barre syndrome (Letter). Lancet 338 1142.
261. T.H. Brannagan, A. Pradhan, T. Heimann-Patterson, A.C. Winkelman, M.J. Styler, D.L. Topolsky, P.A. Crilley, R.J. Schwartzman, I. Brodsky and D.E. Gladstone (2002) High-dose cyclophosphamide without stem-cell rescue for refractory CIDP. Neurology 58 1856-1858.
262. W.F. Clark, G.A. Rock, N. Buskard, K.H. Shumak, P. LeBlond, D. Anderson and D.M. Sutton (1999) Therapeutic plasma exchange: An update from the Canadian apheresis group. Ann. Intern. Med. 131 453-462.
263. M.G. Robson, M.J. Walport and K.A. Davies (1994) Systemic lupus erythematosus and acute demyelinating polyneuropathy. Br. J. Rheumatol. 33 1074-1077.
264. W.S. Fleet and R.T. Watson (1986) Autoimmune optic neuritis: A potentially treatable form of visual loss. Ann. Ophthalmol. 18 144-146.
265. Y. Sherer, S. Hassin, Y. Shoenfeld, Y. Levy, A. Livneh, A. Ohry and P. Langevitz (2002) Transverse myelitis in patients with antiphospholipid antibodies—the importance of early diagnosis and treatment. Clin. Rheumatol. 21 207-210.
266. V. Harisdangkul, D. Doorenbos and S.H. Subramony (1995) Lupus transverse myelopathy: Better outcome with early recognition and aggressive high-dose intravenous corticosteroid pulse treatment. J. Neurol. 242 326-331.
267. D.I. Slovick (1986) Treatment of acute myelopathy in systemic lupus erythematosus with plasma exchange and immunosuppression. (Letter). J. Neurol. Neurosurg. Psychiatry 49 103-105.
268. G. Valesini, R. Priori, A. Francia, G. Balestrieri, A. Tincani, P. Airo, R. Cattaneo, A. Zambruni, B. Troianello, M. Chofflon and P.A. Miescher (1994) Central nervous system involvement in systemic lupus Erythematosus: A new therapeutic approach with intrathecal dexamethasone and methotrexate. Springer Semin. Immunopathol. 16 313-321.
269. T.F. Yang, S.S. Lee, P.H. Lin, H. Chen and R.C. Chan (2002) Effect of selective posterior rhizotomy on transverse myelitis in a patient with systemic lupus erythematosus. Am. J. Phys. Med. Rehabil. 81 467-468.
270. S. Padeh and J.H. Passwell (1996) Systemic lupus erythematosus presenting as idiopathic intracranial hypertension. J. Rheumatol. 23 1266-1268.
271. K.M. Heilman, W.C. Kohler and P.C. LeMaster (1971) Haloperidol treatment of chorea associated with systemic lupus erythematosus. Neurology 21 963-965.
272. D. Thomas, P.D. Byrne and R.L. Travers (1979) Systemic lupus erythematosus presenting as post-partum chorea. Aust. N. Z. J. Med. 9 568-570.
273. D.B. Drachman, R.J. Jones and R.A. Brodski (2003) Treatment of refractory myasthenia: “Rebooting” with high-dose cyclophosphamide. Ann. Neurol. 53 29-34.
274. I.R. Mackay and M. Smalley (1966) Results of thymectomy in systemic lupus erythematosus: Observations on clinical course and serological reactions. Clin. Exp. Immunol. 1 129-138.
275. F.M. Grinlinton, N.M. Lynch and H.H. Hart (1991) A pair of monozygotic twins who are concordant for myasthenia gravis but became discordant for systemic lupus erythematosus post-thymectomy. Arthritis Rheum. 34 916-919.
276. R. Gerli, R. Paganelli, A. Cossarizza, C. Muscat, G. Piccolo, D. Barbieri, S. Mariotti, D. Monti, O. Bistoni, E. Raiola, F.M. Venenzi, A. Bertotto and C. Franceschi (1999) Long-term immunologic effects of thymectomy in patients with myasthenia gravis. J. Allergy Clin. Immunol. 103(5), 865-872. Part 1